Alejandro Mjica - Vitro SAB S Board
| VITROA Stock | MXN 8.90 0.10 1.11% |
Insider
Alejandro Mjica is S Board of Vitro SAB de
| Age | 69 |
| Phone | 52 81 8863 1600 |
| Web | https://www.vitro.com |
Vitro SAB Management Efficiency
The company has return on total asset (ROA) of 0.0263 % which means that it generated a profit of $0.0263 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0649) %, meaning that it generated substantial loss on money invested by shareholders. Vitro SAB's management efficiency ratios could be used to measure how well Vitro SAB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Engineer Garcia | Grupo Carso SAB | 62 | |
| Hark Park | Samsung Electronics Co | 59 | |
| JongHee Han | Samsung Electronics Co | 61 | |
| Daniel Janki | Delta Air Lines | 54 | |
| Tilak Mandadi | CVS Health | 59 | |
| David Falkowski | CVS Health | N/A | |
| Robert Rivkin | United Airlines Holdings | 62 | |
| John Laughter | Delta Air Lines | 52 | |
| TaeMoon Roh | Samsung Electronics Co | 55 | |
| Josh Earnest | United Airlines Holdings | N/A | |
| William Carroll | Delta Air Lines | 65 | |
| Laurie Havanec | CVS Health | 62 | |
| JaeYong Lee | Samsung Electronics Co | 55 | |
| William Lentsch | Delta Air Lines | 55 | |
| HyunChong Kim | Samsung Electronics Co | N/A | |
| Larry McGrath | CVS Health | N/A | |
| JungBae Lee | Samsung Electronics Co | 56 | |
| Alan MD | CVS Health | 61 | |
| Doreen Burse | United Airlines Holdings | N/A | |
| Carlos Helu | Grupo Carso SAB | 77 | |
| Jaeseung Lee | Samsung Electronics Co | 63 | |
Management Performance
| Return On Equity | -0.0649 | |||
| Return On Asset | 0.0263 |
Vitro SAB de Leadership Team
Elected by the shareholders, the Vitro SAB's board of directors comprises two types of representatives: Vitro SAB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vitro. The board's role is to monitor Vitro SAB's management team and ensure that shareholders' interests are well served. Vitro SAB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vitro SAB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mario Gomez, Independent Director | ||
| Adrin Meouchi, VP Relations | ||
| Ral Hinojosa, Legal Advisor | ||
| David Guzman, Director | ||
| Jaime Puche, Independent Director | ||
| Claudio Cabello, Chief Admin. and Financial Officer and Chief Restructuring Officer | ||
| Jaime Garza, Director | ||
| Tomas Sada, Director, Chairman of Cydsa, CEO of Cydsa and President of Cydsa | ||
| Guillermo Martinez, Independent Director | ||
| Javier Santos, Legal Counsel | ||
| Ricardo Maiz, Pres Glass | ||
| Alejandro Mjica, S Board | ||
| Joaquin Guajardo, Independent Director | ||
| Alfonso Tamez, CHRO Improvement | ||
| Jose Contreras, Pres Industries | ||
| Ricardo Touche, Director | ||
| Shlomo Frymerman, Pres Division | ||
| Alvaro Garza, Director | ||
| Adrian Cueva, CEO, Director, Member of Chairmanship Committee and President of The Glass Containers Bus. Unit | ||
| Adrian Gonzalez, Chairman of the Board | ||
| Ricardo Bringas, Independent Director |
Vitro Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vitro SAB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0649 | |||
| Return On Asset | 0.0263 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 22.9 B | |||
| Shares Outstanding | 470.03 M | |||
| Shares Owned By Insiders | 78.69 % | |||
| Shares Owned By Institutions | 1.72 % | |||
| Price To Earning | 271.65 X | |||
| Price To Book | 0.43 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Vitro Stock
Vitro SAB financial ratios help investors to determine whether Vitro Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vitro with respect to the benefits of owning Vitro SAB security.